https://policyresearch.jnj.com/340b 2025-10-07T17:09:21-04:00 https://policyresearch.jnj.com/value 2025-10-07T16:35:02-04:00 https://policyresearch.jnj.com/access 2025-10-07T16:55:09-04:00 https://policyresearch.jnj.com/innovation 2025-10-07T16:55:24-04:00 https://policyresearch.jnj.com/fda-approval-programs 2025-10-07T16:56:01-04:00 https://policyresearch.jnj.com/resource-utilization-and-patient-access 2025-10-07T16:57:46-04:00 https://policyresearch.jnj.com/prescription-drug-affordability-boards-pdabs-and-upper-payment-limits-upls 2025-10-07T16:58:16-04:00 https://policyresearch.jnj.com/report 2025-10-07T16:58:34-04:00 https://policyresearch.jnj.com/infographic 2025-10-07T16:59:00-04:00 https://policyresearch.jnj.com/letter 2025-10-07T16:59:11-04:00 https://policyresearch.jnj.com/executive-summary 2025-10-07T17:00:11-04:00 https://policyresearch.jnj.com/r-d 2025-10-07T17:00:23-04:00 https://policyresearch.jnj.com/transparency-reports 2025-10-07T17:00:35-04:00 https://policyresearch.jnj.com/innovation-r-d 2025-10-07T17:03:45-04:00 https://policyresearch.jnj.com/price-controls 2025-10-07T17:04:12-04:00 https://policyresearch.jnj.com/whitepaper 2025-10-07T17:04:31-04:00 https://policyresearch.jnj.com/value-assessment 2025-10-07T17:04:49-04:00 https://policyresearch.jnj.com/insurance-design-reform-pbms 2025-10-07T17:05:02-04:00 https://policyresearch.jnj.com/research-tag 2025-11-24T17:59:02-05:00 https://policyresearch.jnj.com/commentary 2025-10-07T17:05:50-04:00 https://policyresearch.jnj.com/research-utilization 2025-10-07T17:11:11-04:00 https://policyresearch.jnj.com/how-the-fdas-accelerated-approval-program-extended-cancer-survival 2025-12-01T10:44:49-05:00 https://policyresearch.jnj.com/rethinking-cost-sharing-in-health-insurance-aligning-incentives-with-value-based-care 2025-12-01T10:17:07-05:00 https://policyresearch.jnj.com/why-accounting-for-heterogeneity-matters-in-u-s-economic-analyses 2025-10-24T11:39:25-04:00 https://policyresearch.jnj.com/how-patients-view-copay-cards-and-copay-adjustment-policies 2025-12-01T10:45:28-05:00 https://policyresearch.jnj.com/can-public-funding-fully-replace-private-pharma-r-d 2025-10-24T11:34:59-04:00 https://policyresearch.jnj.com/transparency/42-8-billion-breaking-it-down 2025-11-24T16:18:00-05:00 https://policyresearch.jnj.com/transparency/rebates-discounts-and-fees 2025-11-24T16:17:24-05:00 https://policyresearch.jnj.com/transparency/12-things-to-know-about-j-js-340b-rebate-model-policy 2025-09-29T21:18:05-04:00 https://policyresearch.jnj.com/transparency/how-insurers-divert-co-pay-support-meant-for-patients 2025-11-24T17:22:06-05:00 https://policyresearch.jnj.com/transparency/2023-pricing-transparency-report 2026-03-13T18:24:40-04:00 https://policyresearch.jnj.com/measuring-biopharmaceutical-r-d-a-comprehensive-approach 2025-10-24T11:30:05-04:00 https://policyresearch.jnj.com/transparency/letter-in-response-to-hrsa 2025-09-30T20:29:52-04:00 https://policyresearch.jnj.com/transparency/johnson-johnson-rebate-model-summary-letter 2025-09-30T20:25:47-04:00 https://policyresearch.jnj.com/transparency/2022-u-s-pricing-transparency-report 2025-11-24T16:17:03-05:00 https://policyresearch.jnj.com/transparency/the-340b-program 2025-12-01T10:46:00-05:00 https://policyresearch.jnj.com/transparency/2021-janssen-u-s-transparency-report 2025-11-24T16:16:46-05:00 https://policyresearch.jnj.com/transparency/2020-janssen-u-s-transparency-report 2025-11-24T16:16:23-05:00 https://policyresearch.jnj.com/transparency/2016-janssen-u-s-transparency-report 2025-11-24T16:14:35-05:00 https://policyresearch.jnj.com/transparency/2017-janssen-u-s-transparency-report 2025-11-24T16:15:00-05:00 https://policyresearch.jnj.com/transparency/2018-janssen-u-s-transparency-report 2025-11-24T16:15:30-05:00 https://policyresearch.jnj.com/transparency/2019-janssen-u-s-transparency-report 2025-11-24T16:16:04-05:00 https://policyresearch.jnj.com/study-shows-2021-global-pharmaceutical-r-d-investment-reached-276b 2025-11-24T18:03:17-05:00 https://policyresearch.jnj.com/assessment-of-racial-ethnic-inequities-in-copay-card-utilization-enrollment-in-copay-adjustment-programs 2025-10-24T11:36:43-04:00 https://policyresearch.jnj.com/every-second-counts-the-impact-of-fdas-accelerated-approval-program 2025-10-24T11:26:18-04:00 https://policyresearch.jnj.com/perspectives/why-one-size-fits-all-economics-doesnt-work-in-u-s-healthcare 2025-10-24T11:26:47-04:00 https://policyresearch.jnj.com/perspectives/private-and-public-sector-r-d-make-a-great-marriage-for-innovation 2025-10-24T11:27:36-04:00 https://policyresearch.jnj.com/watch-transparency-report-2023 2025-09-29T21:08:03-04:00 https://policyresearch.jnj.com/perspectives/prescription-drugs-arent-the-main-driver-of-medicaid-spending-in-10-states 2025-10-24T11:29:14-04:00 https://policyresearch.jnj.com/perspectives/does-patient-cost-sharing-in-the-u-s-impact-wasteful-healthcare-spending-or-burden-the-sick 2025-10-24T11:29:38-04:00 https://policyresearch.jnj.com/transparency/2024-transparency-report-infographic 2026-03-13T18:26:19-04:00 https://policyresearch.jnj.com/perspectives/transparency-report-shows-need-for-patient-centered-reform 2025-10-07T22:28:25-04:00 https://policyresearch.jnj.com/transparency/2024-pricing-transparency-report-rebates-discounts-fees-by-recipient 2026-03-13T18:20:44-04:00 https://policyresearch.jnj.com/transparency/2024-transparency-report-rebates-discounts-fees 2026-03-13T18:17:37-04:00 https://policyresearch.jnj.com/perspectives/are-340b-hospitals-reaching-those-most-in-need 2025-09-29T22:03:04-04:00 https://policyresearch.jnj.com/research/ensuring-patient-access/are-340b-hospital-child-sites-reaching-underserved-communities 2025-11-24T18:01:47-05:00 https://policyresearch.jnj.com/perspectives/data-shows-how-340b-abuse-is-enriching-large-health-systems-at-patients-expense 2025-09-29T21:33:52-04:00 https://policyresearch.jnj.com/transparency/2025-the-340b-program-infographic 2026-03-13T18:15:41-04:00 https://policyresearch.jnj.com/perspectives/exploring-incentives-for-innovation-and-the-r-d-ecosystem 2025-10-08T09:27:40-04:00 https://policyresearch.jnj.com/perspectives/follow-on-innovation-anything-but-trivial 2025-11-24T18:12:05-05:00 https://policyresearch.jnj.com/perspectives/expert-insights-what-do-we-know-about-the-340b-program-a-conversation-with-professor-neal-masia 2025-11-24T18:12:18-05:00 https://policyresearch.jnj.com/perspectives/cbo-report-confirms-analyses-that-americans-pay-a-steep-price-for-runaway-340b-costs 2025-11-24T18:12:28-05:00 https://policyresearch.jnj.com/perspectives/is-the-340b-program-fueling-nonprofit-hospital-consolidation 2025-10-09T16:02:40-04:00 https://policyresearch.jnj.com/research/ensuring-patient-access/does-the-340b-program-unintentionally-reinforce-patterns-of-hospital-consolidation-in-the-united-states 2025-11-24T18:01:26-05:00 https://policyresearch.jnj.com/perspectives/are-chronic-disease-patients-being-left-behind 2026-01-15T14:26:54-05:00 https://policyresearch.jnj.com/perspectives/research-highlights-the-arbitrary-nature-of-thresholds-in-cost-effectiveness-analysis 2025-11-24T18:05:07-05:00 https://policyresearch.jnj.com/research/valuing-pharmaceuticals-in-the-us/are-cost-effectiveness-analysis-thresholds-fit-for-purpose-for-u-s-decision-making 2025-11-24T17:55:55-05:00 https://policyresearch.jnj.com/perspectives/data-driven-senate-hearing-underscores-bipartisan-support-for-340b-reform 2025-10-28T10:33:52-04:00 https://policyresearch.jnj.com/perspectives/why-state-price-control-efforts-on-prescription-drugs-are-missing-the-mark 2025-11-07T10:16:37-05:00 https://policyresearch.jnj.com/research/valuing-pharmaceuticals-in-the-u-s/are-state-prescription-drug-affordability-boards-pdabs-and-upper-payment-limits-upls-achieving-their-intended-goals 2025-11-24T18:04:44-05:00 https://policyresearch.jnj.com/research/policy-research-center/j-j-research-drives-the-policy-discussion-at-amcp-nexus 2025-11-06T11:00:29-05:00 https://policyresearch.jnj.com/transparency/americas-intellectual-property-system-infographic 2026-03-13T18:13:28-04:00 https://policyresearch.jnj.com/perspectives/u-s-value-assessments-need-to-reflect-actual-prices-and-how-they-change-over-time 2025-11-25T17:16:59-05:00 https://policyresearch.jnj.com/research/valuing-pharmaceuticals-in-the-u-s/tailoring-generalized-cost-effectiveness-analysis-gcea-to-the-u-s-setting-the-importance-of-using-the-right-prices 2025-11-25T17:17:31-05:00 https://policyresearch.jnj.com/perspectives/intellectual-property-the-backbone-of-american-innovation 2025-12-23T12:39:13-05:00 https://policyresearch.jnj.com/transparency/transparency-report-video 2026-03-17T11:50:30-04:00 https://policyresearch.jnj.com/research/ensuring-patient-access/non-medical-switching-among-afib-patients-disruptions-in-treatment 2025-12-23T13:36:02-05:00 https://policyresearch.jnj.com/research/ensuring-patient-access/are-employer-sponsored-health-plans-meeting-the-needs-of-patients-with-chronic-disease 2025-12-23T13:36:32-05:00 https://policyresearch.jnj.com/research/ensuring-patient-access/how-do-patients-with-chronic-illness-experience-health-insurance-and-what-do-they-believe-needs-to-change 2025-12-23T13:36:18-05:00 https://policyresearch.jnj.com/perspectives/leading-with-research 2025-12-23T16:15:45-05:00 https://policyresearch.jnj.com/research/ensuring-patient-access/how-does-non-medical-switching-affect-patient-outcomes 2026-01-12T14:10:30-05:00 https://policyresearch.jnj.com/research/ensuring-patient-access/insured-but-not-covered-patient-voices-on-insurance-design 2026-02-18T15:26:22-05:00 https://policyresearch.jnj.com/research/ensuring-patient-access/do-expedited-fda-approvals-translate-to-faster-insurance-coverage 2026-01-27T11:12:14-05:00 https://policyresearch.jnj.com/research/ensuring-patient-access/insurance-design-shapes-affordability-and-access-for-people-with-chronic-disease 2026-02-25T17:24:50-05:00 https://policyresearch.jnj.com/perspectives/expert-insights-on-r-d-interview-with-melanie-whittington 2026-02-18T15:49:06-05:00 https://policyresearch.jnj.com/perspectives/j-j-study-in-nature-journal-reveals-scale-of-investment-in-medical-innovation-with-the-u-s-as-a-global-launch-pad 2026-02-25T12:20:48-05:00 https://policyresearch.jnj.com/perspectives/minnesota-finds-large-hospital-systems-collect-most-340b-profits-while-middlemen-siphon-off-tens-of-millions 2026-03-06T11:52:19-05:00 https://policyresearch.jnj.com/perspectives/perspective-matters-the-importance-of-understanding-lived-experience-in-considering-the-value-of-treatment 2026-03-11T16:44:02-04:00 https://policyresearch.jnj.com/research/ensuring-patient-access/how-do-patients-perspectives-on-retinitis-pigmentosa-differ-from-those-of-the-general-public 2026-03-11T16:44:54-04:00 https://policyresearch.jnj.com/research/ensuring-patient-access/how-do-340b-growth-drivers-vary-by-hospital-size-and-teaching-status 2026-03-25T12:39:20-04:00 https://policyresearch.jnj.com/perspectives/whos-driving-the-surge-in-the-340b-program 2026-03-25T12:40:13-04:00 https://policyresearch.jnj.com/ 2026-03-05T17:53:10-05:00 https://policyresearch.jnj.com/transparency/340b-program-2-0 2026-03-13T18:22:52-04:00 https://policyresearch.jnj.com/the-340b-program/ 2025-11-24T15:18:30-05:00 https://policyresearch.jnj.com/transparency/americas-intellectual-property-system 2026-01-08T10:43:38-05:00 https://policyresearch.jnj.com/influence-of-prescription-drug-affordability-boards-and-upper-payment-limits-on-state-drug-pricing 2026-03-13T18:27:35-04:00 https://policyresearch.jnj.com/research/valuing-pharmaceuticals-in-the-u-s/understanding-state-medicaid-spending-on-prescription-drugs 2025-11-06T16:02:01-05:00 https://policyresearch.jnj.com/research/valuing-pharmaceuticals-in-the-u-s 2026-03-03T17:36:50-05:00 https://policyresearch.jnj.com/research/ensuring-patient-access 2026-03-03T17:37:18-05:00 https://policyresearch.jnj.com/research/the-healthcare-innovation-ecosystem 2026-03-03T17:38:21-05:00 https://policyresearch.jnj.com/perspectives 2026-03-03T17:45:32-05:00 https://policyresearch.jnj.com/all-content 2025-09-12T17:20:20-04:00 https://policyresearch.jnj.com/transparency2024 2025-10-10T18:17:26-04:00 https://policyresearch.jnj.com/research/policy-research-center 2026-03-03T17:35:27-05:00 https://policyresearch.jnj.com/research/policy-research-center/about 2025-10-07T22:44:07-04:00 https://policyresearch.jnj.com/2023-transparency-report-overview 2025-10-09T18:39:51-04:00 https://policyresearch.jnj.com/transparency 2026-03-03T17:44:40-05:00